BGI-Shenzhen Extends Tender Offer For Complete Genomics To Mar. 1

(RTTNews.com) - BGI-Shenzhen said Friday that it, through its wholly-owned subsidiary Beta Acquisition Corp., has extended its all cash tender offer to purchase all outstanding shares of common stock of Complete Genomics, Inc. ( GNOM ) to March 1.

The offer was previously scheduled to expire on Friday, February 22.

Except for the extension of the offer expiration date, all other terms and conditions of the offer remain unchanged.

According to BGI-Shenzhenm the depositary for the offer has indicated that, as of the close of business on February 22, about 30.8 million shares, or about 87%, of common stock of Complete have been validly tendered in and not withdrawn from the offer, including shares of common stock of Complete subject to guaranteed delivery procedures.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com